Literature DB >> 17633152

Evolution of elective neck dissection in N0 laryngeal cancer.

O Gallo1, A Deganello, J Scala, E De Campora.   

Abstract

Management of cervical lymph node metastasis is one of the most challenging problems facing clinicians dealing with head and neck cancer. A retrospective evaluation has been made of results in N0 laryngeal cancer patients treated from 1978 to date by comparing historical data reported in related papers previously published by our institution. The medical records of 2207 consecutive patients with cN0 SCC of the larynx were used as the source of data in the present study. Together with primary treatment, 759 (34.4%) received at least unilateral elective neck dissection, while the remaining 1448 (65.6%) were admitted to a wait-and-see protocol. Overall, in the electively dissected patients (ED): 128 (16.9%) cases were submitted to classical radical neck dissection, while 403 (53.1%) cases were submitted to functional neck dissection (FND) and 228 (30.0%) cases to jugular node dissection (JND, removing Level II, III and IV). In 125 of the ED group, a neck procedure on the contralateral N0 neck was associated, of which 15 were RNDs, 35 FNDs and 75 JNDs, respectively. Based on this large series population, the change in the philosophy was evaluated concerning elective neck treatment in N0 laryngeal cancer, from RND through FND towards JND. As far as concerns the reliability as a staging procedure, no statistically significant difference was found between RND, FND and JND (p = 0.794). The 5-year neck recurrence rate, as estimated by the Kaplan Meier, method, for all ED patients, was 7.7%. No significant difference in the rate of 5-year neck recurrence was detected between RND, FND and JND groups (p = 0.178). In the survival curves, no differences, in terms of actuarial survival by Kaplan Meier analysis, were observed, in our series, as far as concerns type of elective neck dissection performed (p = 0.222). In conclusion, following a critical revision of 25 years' experience, at our Institution, in the management of cN0 necks in laryngeal cancer patients, definitive changes were observed in the surgical approach to the treatment of occult disease in cN0 cases. JND, compared to more extensive neck dissections, did not show statistically significant differences in terms of neck control (p = 0.233), in terms of impact on survival (p = 0.122) and in terms of accuracy as staging procedure (p = 0.794).

Entities:  

Mesh:

Year:  2006        PMID: 17633152      PMCID: PMC2639990     

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Ital        ISSN: 0392-100X            Impact factor:   2.124


  21 in total

1.  Sonographically guided aspiration cytology of neck nodes for selection of treatment and follow-up in patients with N0 head and neck cancer.

Authors:  M W van den Brekel; L C Reitsma; J J Quak; L E Smeele; J C van der Linden; G B Snow; J A Castelijns
Journal:  AJNR Am J Neuroradiol       Date:  1999-10       Impact factor: 3.825

2.  Does unnecessary elective neck treatment affect the prognosis of N0 laryngeal cancer patients?

Authors:  Antonio Sarno; Corso Bocciolini; Alberto Deganello; Salvatore Coscarelli; Oreste Gallo
Journal:  Acta Otolaryngol       Date:  2004-10       Impact factor: 1.494

3.  Neck dissection.

Authors:  H MARTIN; B DEL VALLE; H EHRLICH; W G CAHAN
Journal:  Cancer       Date:  1951-05       Impact factor: 6.860

Review 4.  Role of the regional lymph node in cancer metastasis.

Authors:  T Tachibana; K Yoshida
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

5.  Landmark article Dec 1, 1906: Excision of cancer of the head and neck. With special reference to the plan of dissection based on one hundred and thirty-two operations. By George Crile.

Authors:  G Crile
Journal:  JAMA       Date:  1987-12-11       Impact factor: 56.272

6.  Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract.

Authors:  J P Shah
Journal:  Am J Surg       Date:  1990-10       Impact factor: 2.565

7.  The N0 neck in head and neck cancer patients.

Authors: 
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

8.  Functional neck dissection. A description of operative technique.

Authors:  E Bocca; O Pignataro; C T Sasaki
Journal:  Arch Otolaryngol       Date:  1980-09

9.  Selective jugular node dissection in patients with squamous carcinoma of the larynx or pharynx.

Authors:  R H Spiro; O Gallo; J P Shah
Journal:  Am J Surg       Date:  1993-10       Impact factor: 2.565

10.  Occult metastases in cancer of the larynx and their relationship to clinical and histological aspects of the primary tumor: a four-year multicentric research.

Authors:  E Bocca; C Calearo; I de Vincentiis; T Marullo; G Motta; A Ottaviani
Journal:  Laryngoscope       Date:  1984-08       Impact factor: 3.325

View more
  5 in total

1.  Occult Nodal Disease Prevalence and Distribution in Recurrent Laryngeal Cancer Requiring Salvage Laryngectomy.

Authors:  Andrew C Birkeland; Andrew J Rosko; Mohamad R Issa; Andrew G Shuman; Mark E Prince; Gregory T Wolf; Carol R Bradford; Jonathan B McHugh; J Chad Brenner; Matthew E Spector
Journal:  Otolaryngol Head Neck Surg       Date:  2016-02-16       Impact factor: 3.497

Review 2.  Guidelines for delineation of lymphatic clinical target volumes for high conformal radiotherapy: head and neck region.

Authors:  Hilke Vorwerk; Clemens F Hess
Journal:  Radiat Oncol       Date:  2011-08-19       Impact factor: 3.481

3.  Effectiveness and pitfalls of elective neck dissection in N0 laryngeal cancer.

Authors:  A Deganello; G Gitti; G Meccariello; G Parrinello; G Mannelli; O Gallo
Journal:  Acta Otorhinolaryngol Ital       Date:  2011-08       Impact factor: 2.124

Review 4.  Pharyngocutaneous fistula following total laryngectomy: analysis of risk factors, prognosis and treatment modalities.

Authors:  M Busoni; A Deganello; O Gallo
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-12       Impact factor: 2.124

5.  Surgical nodal management in hypopharyngeal and laryngeal cancer.

Authors:  M C Ketterer; L A Lemus Moraga; U Beitinger; J Pfeiffer; A Knopf; C Becker
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-02-11       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.